The Use of Stem Cell-Derived Organoids in Cancer Treatment Research
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2022, Vol 3, Issue 3
Abstract
Cancer is one of the leading causes of death worldwide. While some forms of cancer are more manageable and nonfatal with treatments like chemotherapy and radiation, other forms are not as manageable and have high fatality rates, such as colorectal cancer. Colorectal cancer most commonly occurs in elderly adults but has the potential to occur at any age. Due to its sometimes-undetectable symptoms, it is often diagnosed at a very late stage. Once diagnosed, there are different levels of treatment. For example, surgical resection, chemotherapy, radiation, or any combination of the three can occur. When tumors are unresectable, patients are often left with little chance of survival, and receive only the extension of survival for a short period of time. While surgical resection, chemotherapy and radiation have had success in some patients, high recurrence rates and a lack of response to treatments have left patients and researchers looking for new treatments that will result in better survival rates for patients. Researchers have begun to answer the calls for new treatments with the discovery of patient-derived organoids. Patient-derived organoids are harvested from adult stem cells in the desired tissue, or from cancer cells in a patient’s tumor. The cells taken from the patient are then grown ex-vivo in conditions that mimic the inside of the body. Organoids have grown to show both structural and physiological similarities to their parent organ. While organoids have not yet grown to be as large and highly vascularized as their parent organ, they have been useful in disease modeling and drug therapy testing. Patient-derived organoids that have been grown ex-vivo have shown to overlap almost completely with their parent organ in terms of genetic sequence and molecular makeup. Due to their high number of genetic similarities, patient-derived organoids have been shown to react the same way to certain drug treatments in a few studies, which allows researchers to provide combinations of different cancer drug treatments that are tailored to each individual patient, rather than using a standardized approach that only seems to work for some patients. Patient-derived organoids are still a rather new approach to cancer drug therapy testing, and they still present some limitations, such as their inability to grow as large and as highly vascularized as their parent organ. While these limitations may have the ability to hinder the effectiveness of patient-derived organoids, some organoids have shown success in colorectal cancer drug therapy trials, and their limitations are likely to be overcome as more information is known about patient-derived organoids. Organoids are a promising approach to the treatment of colorectal cancer and have the potential to help save more patients than previous approaches.
Authors and Affiliations
Amanda Geissler1, Vincent S Gaillicchio1*
Keywords
Related Articles
- EP ID EP711265
- DOI https://doi.org/10.46889/JRMBR.2022.3302
- Views 49
- Downloads 0
Numerous Types of Stem Cells Possess Potential to Treat Congenital Hydrocephalus
Twenty-five percent of premature neonate’s experience Intraventricular Hemorrhage (IVH) and 10% of these events are complicated further by the occurrence of hydrocephalus. The number of infants at high risk for IVH and t...
Bioregenerative Applications of the Human Mesenchymal Stem Cell- Derived Secretome: Part-II
This literature review analyzes the results from studies applying conditioned medium and extracellular vesicles derived from the mesenchymal stem cell secretome to numerous disease states in animal and human in-vivo mode...
Bone Marrow Mesenchymal Stem Cell Secretome from Acute Patients Reveals a Distinct Signature
Objective: Stem cells play a pivotal role in wound healing. Understanding the interplay of chemical signals governing wound healing in different settings could inform on novel strategies to improve outcomes. Before exami...
The Jounced Entrails-Intestine in COVID-19
Coronavirus disease 2019 (COVID-19), initiated by contemporary coronavirus is a pandemic which engenders severe respiratory disease. SARS-CoV-2 preponderantly transmits through airborne particles and mammoth respirator...
Use of Pulsed Electromagnetic Fields in Treatment of Benign Prostatic Hypertrophy: Three Case Studies
Benign Prostatic Hypertrophy (BPH) is the most common benign urological condition in males. It is a progressive condition associated with aging, affecting over 80% by age 80 and can affect quality of life. While the exac...